T Cells Target an Enzyme Associated With Gut Microbiota in Multiple Sclerosis (1 of 2) (IMAGE)
Caption
Immunologist Mireia Sospedra (back), Raquel Planas (front) and Paula Ojer-Tomas (middle), members of the team that identified a new candidate autoantigen in multiple sclerosis. This material relates to a paper that appeared in the Oct. 10, 2018, issue of Science Translational Medicine, published by AAAS. The paper, by R. Planas at University Hospital Zurich in Zürich, Switzerland; and colleagues was titled, "GDP-L-fucose Synthase is a CD4+ T cell-specific autoantigen in DRB3*02:02 multiple sclerosis patients."
Credit
Neuroimmunology and Multiple Sclerosis Research, University Hospital Zurich, Switzerland)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content